SciELO - Scientific Electronic Library Online

 
vol.38 issue4Tuberculosis, HIV, and poverty: temporal trends in Brazil, the Americas, and worldwideUnilateral pulmonary agenesis author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Article

Indicators

Related links

  • Have no similar articlesSimilars in SciELO

Share


Jornal Brasileiro de Pneumologia

Print version ISSN 1806-3713

J. bras. pneumol. vol.38 no.4 São Paulo July/Aug. 2012

http://dx.doi.org/10.1590/S1806-37132012000400015 

BRIEF COMMUNICATION

 

Evolution of public policies and programs for asthma control in Brazil from the perspective of consensus guidelines*

 

 

Lígia Menezes do AmaralI; Pamella Valente PalmaII; Isabel Cristina Gonçalves LeiteIII

IPulmonologist. Universidade Federal de Juiz de Fora - UFJF, Federal University of Juiz de Fora - University Hospital, Juiz de Fora, Brazil
IIDental Student. Universidade Federal de Juiz de Fora - UFJF, Federal University of Juiz de Fora - School of Dentistry, Juiz de Fora, Brazil
IIIAdjunct Professor. Universidade Federal de Juiz de Fora - UFJF, Federal University of Juiz de Fora - School of Medicine, Juiz de Fora, Brazil

Correspondence to

 

 


ABSTRACT

There is much discussion about effective public policies that allow the proper treatment of asthma, providing care that is comprehensive and centered on asthma patients within their social context. Educating health professionals and asthma patients provides better recognition of symptoms and the triggers of asthma exacerbations, as well as disseminating strategies for avoiding such triggers, thereby ensuring better treatment and quality of life for asthma patients. Asthma imposes an ever-increasing burden on society, in terms of impaired quality of life, morbidity, and health care costs, making this a very important discussion in the field of public policy.

Keywords: Health policy; Asthma; Consensus.


 

 

Asthma imposes an ever-increasing burden on society, in terms of impaired quality of life, morbidity, and health care costs. The fact that the population with a lower income and a lower level of education is more vulnerable to the morbidity caused by asthma is often attributed to issues of access to health care services and drugs, as well as to educational issues.(1-3) It is therefore imperative to discuss asthma in the field of public policy.

In 1996, the Brazilian Thoracic Association, the Brazilian Association of Allergists and Immunopathologists, and the Brazilian Society of Pediatrics published the First Brazilian Consensus on Asthma Education,(4) drawing a plan for asthma education and control. Chart 1 summarizes the issues addressed in the Brazilian consensus guidelines for asthma.

In various Brazilian cities, programs were created in an attempt to meet the goals set by the First Brazilian Consensus on Asthma Education (Figure 1). In 1996, a program designated Criança que Chia (Wheezing Child)-a joint venture of the Belo Horizonte Municipal Department of Health and the Pediatric Pulmonology Department of the Federal University of Minas Gerais Hospital das Clínicas-was implemented. The primary objective of the program was to reduce the morbidity and mortality from respiratory diseases in children, particularly the morbidity and mortality from pneumonia and asthma. Before the implementation of the program, treatment was based exclusively on emergency room visits and patient follow-up was inadequate, which resulted in high hospitalization rates. The remaining objectives of the program were as follows(5,6):

• to invest in the training of health care teams and in the education of patients and family members regarding asthma

• to reorganize the care provided to children with asthma, involving the different levels of health care

• to provide inhaled medications for exacerbation control and maintenance therapy

In 1996, the Program for Integrated Health Care for Children with Asthma in Fortaleza, Brazil, was implemented, with the objectives of reducing morbidity, improving patient perception of disease progression, reducing the need for emergency room visits, and reducing the number of hospitalizations for asthma, therefore reducing the costs of the disease.(5-7) In March of 1996, the Program for the Treatment of Asthma Patients in São Luís, Brazil, was created.(5,6)

In 1998, the Brazilian National Ministry of Health issued Decree no. 3,916/GM/MS, thereby creating the National Drug Policy (as part of the process of decentralization of health care in Brazil) and facilitating access to certain medications for asthma control.(5)

In 1999, the Brazilian Thoracic Association, the Brazilian Association of Allergists and Immunopathologists, and the Brazilian Society of Pediatrics, together with the Brazilian Clinical Medicine Society and the Brazilian National Ministry of Health, committed themselves to establishing guidelines for the creation of the Plano Nacional de Controle da Asma (PNCA, National Asthma Control Plan). In 2001, after extensive discussions, the Carta de Salvador (Salvador Charter) was delivered to the Brazilian National Ministry of Health, drawing attention to the urgency of implementing the PNCA in order to provide asthma treatment via the Brazilian Unified Health Care System.(8,9) In 1999, the Program for the Treatment of Asthma Patients in the Federal District of Brasília, Brazil, was created.(5,9)

In 2000, the state of Paraná, Brazil, launched its own control program, designated Programa Crescendo com Saúde - Infecções e Alergias Respiratórias na Infância (Growing up Healthy - Respiratory Infections and Allergies in Children). In 2001, the city of Porto Alegre, Brazil, launched its own program, designated De Volta para Casa e Asma (Going Home and Asthma).(5)

On June 23, 2002, the Brazilian National Ministry of Health issued Decree no. 1,318/GM,(10) which was updated by Decree no. 921/SAS/MS, issued in November of 2002,(11) whereby the Brazilian Department of Health Care was charged with taking the necessary measures to create treatment guidelines and clinical protocols for patients with severe asthma, to whom drugs such as beclomethasone, budesonide, fenoterol, formoterol, albuterol, and salmeterol were to be exclusively provided. Also in 2002, an asthma control program designated Respira Londrina (Breathe, Londrina) was implemented in the city of Londrina, Brazil, in order to prevent asthma attacks, promoting strategies for the treatment of asthma patients via the primary health care system.(5)

In 2003, the Goiás State Department of Health, in partnership with the Federal University of Goiás School of Medicine, developed the Municipal Asthma Plan, which was subsequently designated Catavento - Programa de Controle da Asma de Goiânia (Pinwheel - Goiânia Asthma Control Program).(5) Another program that began to be developed in 2003 was the Plan for Asthma Control in the City of Niterói, Brazil, which was based on the Brazilian National Ministry of Health PNCA. The program consisted of two levels of health care, namely primary health care and tertiary health care, the former being provided via primary health care clinics, family health programs, and community clinics and the latter being provided via a system of referral and counter-referral.(5)

In 2004, as part of what would later become the Brazilian National Policy for Integrated Respiratory Care, the Primary Health Care Guidelines for Asthma and Rhinitis were published, with the objective of broadening the scope of the health care provided to such patients, which was limited to symptomatic treatment of asthma exacerbations. Also in 2004, the Londrina asthma control program came to include all 52 family health care clinics in the city. In the same year, the Feira de Santana Asthma and Allergic Rhinitis Control Program was implemented in Feira de Santana-the second most populous city in the state of Bahia, Brazil-with the objectives of controlling the two diseases and reducing the numbers of emergency room visits, hospitalizations, and deaths.(11-14)

In 2004, by means of a bidding process, 848,560 flasks of beclomethasone dipropionate aerosol (250 µg/dose), 864,000 flasks of beclomethasone dipropionate aerosol (50 µg/dose), and 293,256 flasks of albuterol aerosol (100 µg) were acquired, an investment totaling R$ 32,685,232.36. The drugs were distributed in the 2004-2005 period to the cities in which the Family Health Program had been implemented. In 2004, the process of development and implementation of the Feira de Santana Asthma and Allergic Rhinitis Control Program began, with the participation of the Bahia State Asthma and Allergic Rhinitis Control Program. The program resulted in a significant reduction in mortality, in the number of emergency room visits, and in the rates of hospitalization for asthma in the following year.(5)

In 2004, in the city of Rio de Janeiro, Brazil, the Health Care Plan for Asthma and Rhinitis Patients in the City of Rio de Janeiro was developed. The overall objective was to reduce the morbidity and mortality from asthma among residents of the city of Rio de Janeiro. Specific objectives included training health professionals, promoting continuing education for health professionals, improving the information system, and increasing the coverage of asthma patient follow-up by establishing new asthma referral centers. In 2006, there were 33 such facilities for children with asthma. Of those 33, 3 provided treatment to children with severe asthma and 30 provided treatment to children with mild to moderate asthma. Another 16 facilities provided treatment to adult asthma patients. The Rio de Janeiro program resulted in a reduction in hospitalizations and emergency room visits.(5)

Brazilian National Ministry of Health Decree no. 2,084(13) allocated R$ 0.95/inhabitant per year for the treatment of asthma and rhinitis at the state and municipal levels, under agreements established by the Comissões Intergestores Bipartites (Bipartite Leadership Committees). At that time, the states of Minas Gerais, Amapá, Amazonas, and Pará, as well as some cities in the state of Paraíba, chose not to distribute the federal resources allocated to asthma and rhinitis expenditures.(9) In 2005, the Santa Casa Sisters of Mercy Hospital Complex in Vitória, Brazil, in partnership with the Vitória City Hall, created the Asthma Referral Center for adolescents and adults in the city (with a multidisciplinary team) as part of the Santa Casa Sisters of Mercy Hospital Complex Asthma and Rhinitis Control Program.(5,13)

In May of 2006, the year in which the Fourth Brazilian Guidelines for Asthma Management were published, representatives of medical associations, of the Brazilian National Ministry of Health, and of thirteen asthma programs that were currently active met in Brasília, Brazil, in order to discuss the core aspects of those programs, i.e., professional training, planning, implementation, epidemiological coverage, funding, and results. The representatives discussed the importance of developing public policies for asthma in the context of integrated health care and health surveillance, on the basis of the experience accumulated in the various programs existing in the country at that time.(15)

In January of 2007, Brazilian National Ministry of Health Decree no. 204/GM regulated the allocation of federal resources to health care activities and services in the form of block funding, such allocation being monitored and controlled. Chapter II of Decree no. 204/GM deals with the purchase of drugs and materials for pharmaceutical services provided under various programs, including the asthma and rhinitis program.(12)

In November of 2009, Brazilian National Ministry of Health Decree no. 2,981 approved the specialized component of pharmaceutical care, and, in December of 2010, Brazilian National Ministry of Health Decree no. 4,217(16) approved the norms for the funding and implementation of the Basic Component of Pharmaceutical Care, the asthma and rhinitis program receiving drugs on the National Drug List of the Basic Component of Pharmaceutical Care.(7)

In 2012, the Brazilian Thoracic Association Guidelines for Asthma Management were published, again emphasizing the components of the health care provided to asthma patients. In May of 2012, a program designated Brasil Carinhoso (A Caring Brazil) was launched, consisting of a set of measures aimed at reducing childhood poverty; one of the measures is the free distribution of three drugs for the treatment of asthma (ipratropium bromide, beclomethasone, and albuterol) via the Saúde Não Tem Preço (Health Is Priceless) program.(17,18)

Effective public policies that allow appropriate asthma treatment that is centered on asthma patients within their social context have long been called for. In the Fourth Brazilian Guidelines for Asthma Management,(15) Cerci Neto, Ferreira Filho, and Bueno concluded that there is a satisfactory number of health professionals involved and that the environment is favorable, given that full public funding is provided for the programs. However, we emphasize the importance of a better use of public health strategies, such as family health programs, outreach, humanization, and community health programs, in order to offer high-quality integrated health care to the greatest possible number of asthma patients.(19,20)

 

References

1. Braman SS. The global burden of asthma. Chest. 2006;130(1):4S-12S. PMid: 16840363        [ Links ]

2. Fuhlbrigge AL, Adams RJ, Guilbert TW, Grant E, Lozano P, Janson SL, et al. The burden of asthma in the United States: level and distribution are dependent on interpretation of the national asthma education and prevention program guidelines. Am J Respir Crit Care Med. 2002;166(8):1044-9. http://dx.doi.org/10.1164/rccm.2107057         [ Links ]

3. Nogueira KT, Silva JR, Lopes CS. Qualidade de vida em adolescentes asmáticos: avaliação da gravidade da asma, comorbidade e estilo de vida. J Ped. 2009;85(6):523-30. http://dx.doi.org/10.1590/S0021-75572009000600009         [ Links ]

4. Sociedade Brasileira de Pneumologia e Tisiologia. I Consenso Brasileiro de Educação em Asma. J Pneumol. 1996;22 Suppl 1:S1-S24.         [ Links ]

5. Cerci Neto A, Ferreira Filho OF, Bueno T. Exemplos Brasileiros de programas de controle de asma. J Bras Pneumol. 2008;34(2):103-6.         [ Links ]

6. Vale SA. Estudo de utilização dos medicamentos inalatórios no programa "Criança que chia", Secretaria Municipal de Belo Horizonte, MG. [master's thesis]. [Belo Horizonte]: Universidade Federal de Minas Gerais; 2004. 118 p.         [ Links ]

7. Cerci Neto A. Asma em saúde pública. Barueri: Manole; 2007.         [ Links ]

8. Holanda MA, Almeida PC, Sousa CR, Araújo SHFS, Braga AD, Mindêllo MLCB. Características individuais, fatores predisponentes e desencadeantes das crises de asma em crianças do PROAICA [abstract]. J Pneumol. 2001;27 Suppl 2:S4.         [ Links ]

9. Silva LC, Freire LM, Mendes NF, Lopes AC, Cruz A. Carta de Salvador. J Pneumol. 2002;28 Suppl 1:S2.         [ Links ]

10. Portal de Saúde [homepage on the internet]. Brasília: Ministério da Saúde [cited 2012 Apr 20]. Portaria nº 1.318, de 23 de julho de 2002. [Adobe Acrobat document, 64p.] Available from: http://portal.saude.gov.br/portal/arquivos/pdf/portaria_1318.pdf         [ Links ]

11. Portal de Saúde [homepage on the internet]. Brasília: Ministério da Saúde [cited 2012 Apr 20]. Secretaria de Atenção à Saúde. Portaria nº 921, de 16 de novembro de 2002. Available from: http://bvsms.saude.gov.br/bvs/saudelegis/sas/2011/prt0921_16_12_2011.html         [ Links ]

12. Brasil. Ministério da saúde. Portaria nº 204, 29 de janeiro de 2007. Diário Oficial da União, Brasília, 2007 jan 31;n. 22;Seção 1:45.         [ Links ]

13. Portal de Saúde [homepage on the internet]. Brasília: Ministério da Saúde [cited 2012 Apr 20]. Portaria nº 2.084/GM de 26 de outubro de 2005. [Adobe Acrobat document, 13p.] Available from: http://portal.saude.gov.br/portal/arquivos/pdf/Portaria_GM_N_2084.pdf         [ Links ]

14. Brandão, H., Silva Junior I, Neto JN, do Amaral D, Cruz C, Souza-Machado A, et al. Impacto do programa para o controle da asma e da rinite (PROAR) de Feira de Santana, Bahia. Gaz Med Bahia. 2008;78(2):64-8.         [ Links ]

15. Sociedade Brasileira de Pneumologia e Tisiologia. IV Diretrizes Brasileiras para o Manejo da Asma. J Bras Pneumol. 2006;32(Suppl 7):S447-S474.         [ Links ]

16. Brasil. Ministério da saúde. Portaria nº 4217, 28 de dezembro de 2010. Diário Oficial da União, Brasília. 2010 dez 29;n. 249;Seção 1:72-4.         [ Links ]

17. Portal de Saúde [homepage on the internet]. Brasília: Ministério da Saúde [cited 2012 Apr 20]. Brasil Carinhoso I: Farmácia Popular terá remédio de graça para asma. Available from: http://portalsaude.saude.gov.br/portalsaude/noticia/5034/162/farmacia-popular-tera-%3Cbr%3Eremedio-de-graca-para-asma.html         [ Links ]

18. Sociedade Brasileira de Pneumologia e Tisiologia. Diretrizes da Sociedade Brasileira de Pneumologia e Tisiologia para o manejo da asma. J Bras Pneumol. 2012;38(suppl 1):S1-S46.         [ Links ]

19. Portal de Saúde [homepage on the internet]. Brasília: Ministério da Saúde [cited 2012 Apr 20]. Secretaria de Atenção à Saúde. Departamento de Atenção Básica. Asma e rinite: linhas de conduta em atenção básica. Available from http://dtr2001.saude.gov.br/editora/produtos/livros/popup/05_0028.htm         [ Links ]

20. Carmo TA, Andrade SM, Cerci Neto A. Avaliação de um programa de controle da asma em unidades de saúde da família. Cad Saúde Pública. 2011;27(1):162-72. http://dx.doi.org/10.1590/S0102-311X2011000100017         [ Links ]

 

 

Correspondence to:
Lígia Menezes do Amaral
Hospital Universitário, Universidade Federal de Juiz de Fora, Unidade Santa Catarina, Serviço de Clínica Médica
Rua Catulo Breviglieri s/nº, Santa Catarina
CEP 36036-110, Juiz de Fora, MG, Brasil
Tel. 55 32 2102-3830
E-mail: ligia.ma@hotmail.com

Submitted: 20 April 2012.
Accepted, after review: 8 June 2012.
Financial support: Pamella Valente Palma is the recipient of a scholarship from the Programa Institucional de Bolsas de Iniciação Científica (PIBIC, Institutional Program for Scientific Initiation Scholarships) from the Brazilian Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq, National Council for Scientific and Technological Development).

 

 

* Study carried out under the auspices of the Graduate Program in Collective Health, Department of Collective Health, Universidade Federal de Juiz de Fora - UFJF, Federal University of Juiz de Fora - School of Medicine, Juiz de Fora, Brazil.